Lanean...
Neutralizing antibodies against adeno-associated viruses in Sjögren’s patients: implications for gene therapy
One potential setback to the use of gene therapy for the treatment of Sjögren’s syndrome is the presence of neutralizing antibodies (nAb) against adeno-associated virus (AAV) serotypes. In order to evaluate the efficacy of this treatment option, nAb titers were measured in both healthy individuals a...
Gorde:
| Argitaratua izan da: | Gene Ther |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5810933/ https://ncbi.nlm.nih.gov/pubmed/28150697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2017.1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|